Administrative Core (A) is the innovative and synergistic engine driving the Penn CFAR, a collaboration ofthe University of Pennsylvania and its Perelman School of Medicine, Children's Hospital of Philadelphia, and Wistar Institute. Core A establishes and oversees Shared Resource Cores, educational activities, a Developmental Core, mentoring activities of junior investigators, and initiatives that build strong ties to the campus and community. Core A will continue to be led by Director James Hoxie, MD and Co- Director Ronald Collman, MD. Core A works closely with a governing Executive Committee, Internal Advisory Board, External Advisory Committee, and Community Advisory Board. In addition to the Cores, Core A oversees the CFAR's 4 Research Areas (Virology/Pathogenesis, Clinical/Therapeutics, Immunology vaccine, Behavioral &Social Sciences) and the new Scientific Working Groups (SWGs) (Viral Hepatitis &HIV Co-Infection, HIV Eradication &Functional Control, AIDS &Addiction). Core A provides the management and scientific direction for the CFAR and establishes the necessary linkages among participants. Core A's primary responsibilities are to 1) facilitate communication among CFAR members;2) lead a robust and transparent strategic planning process: 3) ensure that opportunities in emerging scientific areas and technologies in HIV/AIDS research are recognized and pursued: 4) ensure that Core facilities serve the research needs of members and comply with the policies by which they were established;5) enforce sound fiscal management and accountability for Core activities and Developmental funds;6) create multidisciplinary and vibrant educational programs for faculty and students;7) provide resources, organizational capacity, and scientific direction to CFAR SWGs;8) pursue strong outreach programs that address the needs of domestic and international populations most affected by the HIV epidemic;9) foster collaborations throughout the national CFAR network: and 10) promote diversity and inclusion in all CFAR activities. Core A is deeply committed to initiatives that build strong ties for the CFAR to the campus and the Philadelphia community, the CFAR network, and to international programs of Core I and inter-CFAR collaborations.

Public Health Relevance

For 14 years, Core A has led the Penn CFAR in creating an interactive and collaborative HIV/AIDS research climate, vibrant educational activities, and innovative community outreach programs. Core A conducts, coordinates, and monitors CFAR activities to build infrastructure that fosters interdisciplinary and translational HIV/AIDS research and provides scientific leadership. It has also played the leadership role in the strategic planning process that has defined the exciting action plan for the next funding period.

Agency
National Institute of Health (NIH)
Type
Center Core Grants (P30)
Project #
2P30AI045008-16
Application #
8697191
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
Budget End
Support Year
16
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Gross, Robert; Bandason, Tsitsi; Langhaug, Lisa et al. (2015) Factors associated with self-reported adherence among adolescents on antiretroviral therapy in Zimbabwe. AIDS Care 27:322-6
Muluneh, Melaku; Shang, Wu; Issadore, David (2014) Track-etched magnetic micropores for immunomagnetic isolation of pathogens. Adv Healthc Mater 3:1078-85
Safren, Steven A; Biello, Katie B; Smeaton, Laura et al. (2014) Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial. PLoS One 9:e104178
Nachega, Jean B; Parienti, Jean-Jacques; Uthman, Olalekan A et al. (2014) Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clin Infect Dis 58:1297-307
Wohl, David A; Arnoczy, Gretchen; Fichtenbaum, Carl J et al. (2014) Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study. Antivir Ther 19:141-7
Zetola, Nicola M; Modongo, Chawangwa; Olabiyi, Bisayo et al. (2014) Examining the relationship between alcohol use and high-risk sex practices in a population of women with high HIV incidence despite high levels of HIV-related knowledge. Sex Transm Infect 90:216-22
Haas, David W; Kwara, Awewura; Richardson, Danielle M et al. (2014) Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes. J Antimicrob Chemother 69:2175-82
Ramirez, Lorenzo A; Daniel, Alexander; Frank, Ian et al. (2014) Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells. J Infect Dis 210:646-50
Liu, Weimin; Li, Yingying; Shaw, Katharina S et al. (2014) African origin of the malaria parasite Plasmodium vivax. Nat Commun 5:3346
Blank, Michael B; Hennessy, Michael; Eisenberg, Marlene M (2014) Increasing quality of life and reducing HIV burden: the PATH+ intervention. AIDS Behav 18:716-25

Showing the most recent 10 out of 235 publications